Cargando…
Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL
NOTCH signaling represents a promising therapeutic target in chronic lymphocytic leukemia (CLL). We compared the anti-neoplastic effects of the nuclear NOTCH2 inhibitor gliotoxin and the pan-NOTCH γ-secretase inhibitor RO4929097 in primary CLL cells with special emphasis on the individual roles of t...
Autores principales: | Hubmann, Rainer, Schnabl, Susanne, Araghi, Mohammad, Schmidl, Christian, Rendeiro, André F., Hilgarth, Martin, Demirtas, Dita, Ali, Farghaly, Staber, Philipp B., Valent, Peter, Zielinski, Christoph, Jäger, Ulrich, Shehata, Medhat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348714/ https://www.ncbi.nlm.nih.gov/pubmed/32570839 http://dx.doi.org/10.3390/cells9061484 |
Ejemplares similares
-
Gliotoxin Targets Nuclear NOTCH2 in Human Solid Tumor Derived Cell Lines In Vitro and Inhibits Melanoma Growth in Xenograft Mouse Model
por: Hubmann, Rainer, et al.
Publicado: (2017) -
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy
por: Kamdje, A H Nwabo, et al.
Publicado: (2012) -
Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells
por: López-Guerra, Mónica, et al.
Publicado: (2019) -
UGT2B17 modifies drug response in chronic lymphocytic leukaemia
por: Allain, Eric P., et al.
Publicado: (2020) -
Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think
por: Lobry, Camille, et al.
Publicado: (2011)